Abstract
Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.
| Original language | English |
|---|---|
| Pages (from-to) | 829-836 |
| Number of pages | 8 |
| Journal | Drugs of Today |
| Volume | 40 |
| Issue number | 10 |
| DOIs | |
| State | Published - Oct 1 2004 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology (medical)
- Pharmacology
Cite this
Treatment of pain symptoms in irritable bowel syndrome patients. / Gupta, Vishal; Moshiree, Baharak; Verne, G. Nicholas.
In: Drugs of Today, Vol. 40, No. 10, 01.10.2004, p. 829-836.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of pain symptoms in irritable bowel syndrome patients
AU - Gupta, Vishal
AU - Moshiree, Baharak
AU - Verne, G. Nicholas
PY - 2004/10/1
Y1 - 2004/10/1
N2 - Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.
AB - Irritable bowel syndrome represents a common gastrointestinal disorder that significantly impacts patients' lives. It is defined by Rome II criteria and characterized by abdominal pain and bloating associated with changes in bowel habit. Visceral hypersensitivity is currently considered a biological marker for the disease. Current therapeutic treatments include the use of fiber supplements, antidiarrheal agents, laxatives, antispasmodics, tricyclic antidepressants and serotonergic agents. Through a proper understanding of the diagnostic criteria, pathophysiology and treatment options, this disorder can be treated effectively in many patients.
UR - http://www.scopus.com/inward/record.url?scp=8744289770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=8744289770&partnerID=8YFLogxK
U2 - 10.1358/dot.2004.40.10.863743
DO - 10.1358/dot.2004.40.10.863743
M3 - Article
VL - 40
SP - 829
EP - 836
JO - Drugs of Today
JF - Drugs of Today
SN - 1699-3993
IS - 10
ER -